Trial intelligence / Profile preview

Acute Effects of Oxygen Supplementation During Exercise in IPF Patients

NCT03688334Completed

Sponsor
G. Papanikolaou General Hospital
Start
Jun 2018
Primary completion
Jun 2019
Modality
Inhalation Devices
Countries
1
01

Overview

Randomised trial of oxygen in idiopathic pulmonary fibrosis (IPF) (2 arms), sponsored by G. Papanikolaou General Hospital. Primary endpoint: Exercise duration. Started Jun 2018; status: completed.

02

Drugs

oxygen
03

Conditions

idiopathic pulmonary fibrosis (IPF)

Beyond the preview

Go deeper on NCT03688334.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03688334.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call